Long-term effectiveness and cost-effectiveness of screening for Hepatitis C virus infection

Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness

1995 • 1,342 citations

The measurement of satisfaction with healthcare: implications for practice from a systematic review of the literature

2002 • 1,208 citations

Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta‐Analysis

2001 • 968 citations

Global surveillance and control of hepatitis C

1999 • 909 citations

National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis B

2009 • 841 citations

Cost-effectiveness analysis.

1993 • 814 citations

Recovery, Persistence, and Sequelae in Hepatitis C Virus Infection: A Perspective on Long-Term Outcome

2000 • 751 citations

[Principles and practice of mass screening for disease].

1968 • 730 citations

Human immunodeficiency virus infection modified the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

1997 • 719 citations

EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999

1999 • 704 citations

Estimating progression to cirrhosis in chronic hepatitis C virus infection

2001 • 628 citations

Cost-Effectiveness of Screening for HIV in the Era of Highly Active Antiretroviral Therapy

2005 • 597 citations

Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study

2006 • 491 citations

Global surveillance and control of hepatitis C

1999 • 441 citations

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV

1992 • 397 citations

Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity

1998 • 312 citations

Acute hepatitis C

2008 • 285 citations

Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis

1992 • 270 citations

EASL International Consensus Conference on Hepatitis C

1999 • 261 citations

National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002-June 10-12, 2002

2002 • 246 citations

Non-A, Non-B Post-Transfusion Hepatitis: Looking Back in the Second Decade

1993 • 239 citations

Surveillance and epidemiology of hepatitis B and C in Europe – a review

2008 • 236 citations

Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV)

1990 • 231 citations

Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation

2006 • 229 citations

Therapy of hepatitis C: Patients with normal aminotransferase levels

1997 • 170 citations

Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling

2006 • 169 citations

Watchful Waiting with Periodic Liver Biopsy versus Immediate Empirical Therapy for Histologically Mild Chronic Hepatitis C: A Cost-Effectiveness Analysis

2000 • 159 citations

When should decision-analytic modeling be used in the economic evaluation of health care?

2003 • 157 citations

Liquid-based cytology in cervical screening: a rapid and systematic review.

2000 • 156 citations

Hepatitis C in asymptomatic blood donors

1997 • 151 citations

Management of Chronic Hepatitis C: Consensus Guidelines

2007 • 134 citations

EASL International Consensus Conference on Hepatitis CParis, 26–27 February 1999Consensus Statement

1999 • 131 citations

NON-A, NON-B POST-TRANSFUSION HEPATITIS

1977 • 122 citations

Outcome of acute symptomatic non‐A, non‐B hepatitis: a 13‐year follow‐up study of hepatitis C virus markers

1993 • 108 citations

Screening for hepatitis C among injecting drug users and in genitourinary medicine (GUM) clinics: systematic reviews of effectiveness, modelling study and national survey of current practice

2002 • 103 citations

Predicting progression to cirrhosis in chronic hepatitis C virus infection

2003 • 96 citations

Is severe liver disease a common outcome for people with chronic hepatitisC?

2002 • 95 citations

Cost effectiveness of screening for hepatitis C virus in asymptomatic, average-risk adults

2001 • 82 citations

Routine hepatitis C virus screening in pregnancy: A cost-effectiveness analysis

2005 • 78 citations

Cost-Effectiveness Analysis of Screening for Celiac Disease in the Adult Population

2006 • 77 citations

The cost-effectiveness of testing for hepatitis C in former injecting drug users

2006 • 74 citations

The German Cervical Cancer Screening Model: development and validation of a decision-analytic model for cervical cancer screening in Germany

2006 • 69 citations

Clinical- and cost-effectiveness of pegylated interferon alfa in the treatment of chronic hepatitis C: A systematic review and economic evaluation

2005 • 47 citations

Screening for Hepatitis C in injecting drug users: a cost utility analysis

2004 • 36 citations

Standardtherapie der akuten und chronischen Hepatitis C

2004 • 33 citations

Case finding for hepatitis C in primary care: a cost utility analysis

2006 • 32 citations

Cost-effectiveness of coronary artery disease screening in asymptomatic patients with type 2 diabetes and other atherogenic risk factors in Japan: Factors influencing on international application of evidence-based guidelines

2006 • 24 citations

What is the cost utility of screening for hepatitis C virus (HCV) in intravenous drug users?

1999 • 24 citations

Screening for hepatitis C in genito-urinary medicine clinics: a cost utility analysis

2003 • 24 citations

PREVENTION COULD BE LESS COST-EFFECTIVE THAN CURE: THE CASE OF HEPATITIS C SCREENING POLICIES IN FRANCE

2003 • 20 citations

The evaluation of the worth of early disease detection.

1968 • 18 citations

Cost-effectiveness analysis of strategies for hepatitis C screening in French blood recipients

2001 • 15 citations

National campaign against hepatitis C in France (1999-2002).

2002 • 12 citations

Hepatitis C and injecting drug use

2004 • 1 citations